374 filings
Page 14 of 19
6-K
bs7je61 1heao
31 Jan 07
Current report (foreign)
12:00am
6-K
af9qlclt20rafqe
16 Jan 07
Ym Biosciences Provides Update on Tesmilifene Pivotal Trial
12:00am
6-K
ljbbdt2
21 Dec 06
Ym Biosciences Partners with Tty Biopharm to Develop Tesmilifene In Taiwan
12:00am
6-K
arufx gyo77k78
13 Nov 06
Ym Biosciences Reports First Quarter 2007
12:00am
6-K
mstm a32a1le
13 Nov 06
Current report (foreign)
12:00am
6-K
vbq8wbq
1 Nov 06
Annual and Special Meeting
12:00am
6-K
fyh2cxdlnexnsldea4cv
18 Oct 06
Ym Biosciences Announces Results of Aerolef™ Phase
12:00am
6-K
s9sksvwfgk7g7ap56
27 Sep 06
Ym Biosciences Announces Aerolef™ Phase Iib Interim Review
12:00am
40-F
honep
25 Sep 06
Annual report (Canada)
12:00am
F-X/A
p4pm9c4 yx9yvd7n
25 Sep 06
Appointment of agent for service of process by issuers registering securities (amended)
12:00am
6-K
5y5781tpg9kxy vynu
25 Sep 06
Ym Biosciences Receives Clearance to Import Nimotuzumab for Clinical Research In the Us
12:00am
6-K
ykxb2yr
22 Sep 06
Ym Biosciences Reports 2006 Year End Operational and Financial Results
12:00am
6-K
o64cbt1jfuik6o y01t
24 Aug 06
Ym Biosciences Announces Independent Data Safety Monitoring Board Recommends Tesmilifene Pivotal Trial Continue As Planned
12:00am
6-K
79nbj7uu
1 Aug 06
Current report (foreign)
12:00am
6-K
jl1i p1bqocrjx
31 Jul 06
Current report (foreign)
12:00am
6-K
f44t1oy3 crn
24 Jul 06
Current report (foreign)
12:00am
6-K
jxovgvj
21 Jul 06
Ym Biosciences Reports Anti-egfr Drug
12:00am
6-K
i292hofr
27 Jun 06
Ym Biosciences Announces Independent Data Safety Monitoring Board Recommends Tesmilifene Pivotal Trial Continue As Planned
12:00am
6-K
brcj7088odmk1f84
7 Jun 06
Current report (foreign)
12:00am
6-K
eznq7m
7 Jun 06
Current report (foreign)
12:00am